Replies to post #312652 on CASH COW

[BlazingStocks]

$NBIO - "Pritumumab offers unexplored potential as an ADC vector, and we are excited to test that promise leveraging our expertise in ADC discovery and development. This could pave the way for applying our newest linker-payload innovations to pritumumab in the future" said Dr. Borys Shor, CEO of Manhattan Bio.
https://finance.yahoo.com/news/nascent-biotech-manhattan-biosolutions-collaborate-120000090.html